Aeris Environmental (ASX:AEI) - Non Executive Chairman, Maurie Stang
Non Executive Chairman, Maurie Stang
Source: Inclean
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Sanitiser company, Aeris Environmental (AEI) has reported record sales revenue of over $4 million for the March quarter, due to COVID-19
  • It has also booked $4.1 million sales for the month of April alone
  • The company’s current revenue run rate for the 2020 financial year is now expected to be over $13 million
  • This month, Aeris completed a $12 million placement that saw strong demand from leading institutional and sophisticated investors
  • Aeris Environmental is down 5 per cent and shares closed at 57 cents each

Sanitiser company, Aeris Environmental (AEI) has reported a record sales revenue of over $4 million for the March quarter, due to the COVID-19 pandemic.

In the past nine months, Aeris has seen a sales revenue of $7.2 million. It has also booked $4.1 million in sales for April alone, with more than $2 million additional orders received.

The company’s current run rate for the 2020 financial year is now expected to be in excess of $13 million.

This month, the company completed a $12 million placement that had strong demand from leading institutional and sophisticated investors.

“Aeris is currently debt-free, cash positive and profitable,” the company said.

The company has expanded its Board with the appointment of Michael Ford, who is currently the Chief Financial Officer (CFO) of News Corp Australia. Micheal has over 30 years of experience in strategy and financial roles.

Aeris said it is on track to increase production, both domestically and internationally. Its products AerisGuard, Aeris Active and Actisan are quickly achieving international registrations and approvals due to COVID-19.

Aeris Environmental ended the day 5 per cent in the red with shares trading for 57¢ each.

AEI by the numbers
More From The Market Online

BlinkLab partnership with US smart-tech Turning Pointe raises hopes for autism kids

BlinkLab partners with US-based Turning Pointe Autism Foundation for clinical study ahead of its FDA registration…

Little Green Pharma closely eyeing USA’s legal downgrade of Cannabis danger

Overnight, the Biden government did something sure to give their counterparts a stir – the USA…

OncoSil’s cancer device shows shrink in pancreatic tumours

OncoSil's cancer device shows shrink in pancreatic tumours at a study conducted at the Royal Adelaide…
The Market Online Video

Why Princeton Professor rates BlinkLab’s autism & ADHD screening app

In this interview with Sonia Madigan, Professor Sam Wang of Princeton University discusses the development and…